Global Oncolytic Virus Immunotherapy Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2020-12-28
- Report ID: 35695
- Pages: 112
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Market's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Oncolytic Virus Immunotherapy market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Oncolytic Virus Immunotherapy Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Oncolytic Virus Immunotherapy Market
BioVex Inc.
Cell Genesys
Crusade Laboratories
Genelux Corporation
Jennerex Biotherapeutics
Lokon Pharma
Merck
MultiVir
Oncolys BioPharma
Oncolytics Biotech
Oncos Therapeutics (Targovax)
PsiOxus Therapeutics
Shanghai Sunway Biotech
Takara Bio
VCN Biosciences
ViroTarg
Vyriad
...
Major Type of Oncolytic Virus Immunotherapy Covered in Prudent Markets report:
Herpes Simplex Virus
Vaccinia Virus
Adenovirus
Reovirus
Others
Application Segments Covered in Prudent Markets Market
Melanoma
Non-small Cell Lung Cancer [NSCLC]
Pancreatic Cancer
Breast Cancer
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Oncolytic Virus Immunotherapy Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Herpes Simplex Virus -Product Introduction and Major Manufacturers
1.1.2 Vaccinia Virus -Product Introduction and Major Manufacturers
1.1.3 Adenovirus -Product Introduction and Major Manufacturers
1.1.4 Reovirus -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.1.1 China Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.1.2 China Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.2.1 EU Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.2.2 EU Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.3.1 USA Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.3.2 USA Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.4.1 Japan Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.4.2 Japan Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.5.1 India Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.5.2 India Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.6.1 Southeast Asia Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.7.1 South America Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.7.2 South America Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Oncolytic Virus Immunotherapy Status and Prospect (2015-2026)
2.8.1 Oncolytic Virus Immunotherapy Market Size and Growth Rate (2015-2026)
2.8.2 Oncolytic Virus Immunotherapy Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Oncolytic Virus Immunotherapy Market Assessment by Segment
3.1 Global Oncolytic Virus Immunotherapy Capacity and Growth Rate
3.2 Global Oncolytic Virus Immunotherapy Sales by Type
3.3 Global Oncolytic Virus Immunotherapy Sales Revenue by Type
3.4 Global Oncolytic Virus Immunotherapy Consumption by Application
4 Global Oncolytic Virus Immunotherapy Market Assessment by Regions
4.1 Global Oncolytic Virus Immunotherapy Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Oncolytic Virus Immunotherapy Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Oncolytic Virus Immunotherapy Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Oncolytic Virus Immunotherapy Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Oncolytic Virus Immunotherapy Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Oncolytic Virus Immunotherapy Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Oncolytic Virus Immunotherapy Sales Market Share of Manufacturers (2019-2020)
6.3 Global Oncolytic Virus Immunotherapy Sales Revenue Market Share of Manufacturers (2019-2020)
7 Oncolytic Virus Immunotherapy Competitive Analysis
7.1 BioVex Inc.
7.1.1 BioVex Inc. Company Profiles
7.1.2 BioVex Inc. Product Introduction
7.1.3 BioVex Inc. Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Cell Genesys
7.2.1 Cell Genesys Company Profiles
7.2.2 Cell Genesys Product Introduction
7.2.3 Cell Genesys Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Crusade Laboratories
7.3.1 Crusade Laboratories Company Profiles
7.3.2 Crusade Laboratories Product Introduction
7.3.3 Crusade Laboratories Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Genelux Corporation
7.4.1 Genelux Corporation Company Profiles
7.4.2 Genelux Corporation Product Introduction
7.4.3 Genelux Corporation Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Jennerex Biotherapeutics
7.5.1 Jennerex Biotherapeutics Company Profiles
7.5.2 Jennerex Biotherapeutics Product Introduction
7.5.3 Jennerex Biotherapeutics Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Lokon Pharma
7.6.1 Lokon Pharma Company Profiles
7.6.2 Lokon Pharma Product Introduction
7.6.3 Lokon Pharma Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Merck
7.7.1 Merck Company Profiles
7.7.2 Merck Product Introduction
7.7.3 Merck Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 MultiVir
7.8.1 MultiVir Company Profiles
7.8.2 MultiVir Product Introduction
7.8.3 MultiVir Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Oncolys BioPharma
7.9.1 Oncolys BioPharma Company Profiles
7.9.2 Oncolys BioPharma Product Introduction
7.9.3 Oncolys BioPharma Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Oncolytics Biotech
7.10.1 Oncolytics Biotech Company Profiles
7.10.2 Oncolytics Biotech Product Introduction
7.10.3 Oncolytics Biotech Oncolytic Virus Immunotherapy Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Oncos Therapeutics (Targovax)
7.12 PsiOxus Therapeutics
7.13 Shanghai Sunway Biotech
7.14 Takara Bio
7.15 VCN Biosciences
7.16 ViroTarg
7.17 Vyriad
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
